Current portfolio

Merus

Innovative full-length bispecific and trispecific antibody therapeutics for oncology.

  • Sector
    Healthcare
  • Country
    Netherlands
  • Fund
    LSP 4
  • Entry
    2010
  • Web
Logo

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180